Cite

HARVARD Citation

    Wada, K. et al. (2015). Biweekly gemcitabine plus S‐1 for locally advanced and metastatic pancreatic cancer: a preliminary feasibility study. Journal of hepato-biliary-pancreatic sciences. pp. 692-698. [Online]. 
  
Back to record